Therapeutic methods for the treatment of hangover
Patent 4593020 Issued on June 3, 1986. Estimated Expiration Date: 
September 24, 2004. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
September 24, 2004. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.InventorAssigneeApplicationNo. 06/654208 filed on 09/24/1984US Classes:514/159, Ortho-hydroxybenzoic acid (i.e., salicyclic acid) or derivative DOAI514/263.31, With perservative, stabilizer, or an additional active ingredient514/556, Inner quaternary ammonium salt (e.g., betaine, etc.)514/629, R is hydrogen or a lower saturated alkyl of less than seven carbons514/811AlcoholExaminersPrimary: Friedman, Stanley J.Attorney, Agent or FirmInternational ClassesA61K 31/60 (20060101)A61K 31/185 (20060101) A61K 31/205 (20060101) A61K 31/52 (20060101) A61K 31/519 (20060101) Foreign Application Priority Data1983-09-24 GBAbstractThis invention relates to therapeutic compositions containing betaine salts for the treatment of hangover and for the lowering of alcohol content in blood in human. Daily dose comprises oral administration of 1 to 30 g, associated with appropriate carrier. Optional ingredients are an analgesic, a buffering agent and caffeine.Other References
| |
